Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors

Julie George, Vonn Walter, Martin Peifer, Ludmil B. Alexandrov, Danila Seidel, Frauke Leenders, Lukas Maas, Christian Müller, Ilona Dahmen, Tiffany M. Delhomme, Maude Ardin, Noemie Leblay, Graham Byrnes, Ruping Sun, Aurélien De Reynies, Anne McLeer-Florin, Graziella Bosco, Florian Malchers, Roopika Menon, Janine Altmüller & 42 others Christian Becker, Peter Nürnberg, Viktor Achter, Ulrich Lang, Peter M. Schneider, Magdalena Bogus, Matthew G. Soloway, Matthew D. Wilkerson, Yupeng Cun, James D. McKay, Denis Moro-Sibilot, Christian G. Brambilla, Sylvie Lantuejoul, Nicolas Lemaitre, Alex Soltermann, Walter Weder, Verena Tischler, Odd Terje Brustugun, Marius Lund-Iversen, Åslaug Helland, Steinar Solberg, Sascha Ansén, Gavin Wright, Benjamin Solomon, Luca Roz, Ugo Pastorino, Iver Petersen, Joachim H. Clement, Jörg Sänger, Jürgen Wolf, Martin Vingron, Thomas Zander, Sven Perner, William D. Travis, Stefan A. Haas, Magali Olivier, Matthieu Foll, Reinhard Büttner, David Neil Hayes, Elisabeth Brambilla, Lynnette Fernandez-Cuesta, Roman K. Thomas

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Pulmonary large-cell neuroendocrine carcinomas (LCNECs) have similarities with other lung cancers, but their precise relationship has remained unclear. Here we perform a comprehensive genomic (n = 60) and transcriptomic (n = 69) analysis of 75 LCNECs and identify two molecular subgroups: "type I LCNECs" with bi-allelic TP53 and STK11/KEAP1 alterations (37%), and "type II LCNECs" enriched for bi-allelic inactivation of TP53 and RB1 (42%). Despite sharing genomic alterations with adenocarcinomas and squamous cell carcinomas, no transcriptional relationship was found; instead LCNECs form distinct transcriptional subgroups with closest similarity to SCLC. While type I LCNECs and SCLCs exhibit a neuroendocrine profile with ASCL1 high/DLL3 high/NOTCH low, type II LCNECs bear TP53 and RB1 alterations and differ from most SCLC tumors with reduced neuroendocrine markers, a pattern of ASCL1 low/DLL3 low/NOTCH high, and an upregulation of immune-related pathways. In conclusion, LCNECs comprise two molecularly defined subgroups, and distinguishing them from SCLC may allow stratified targeted treatment of high-grade neuroendocrine lung tumors.

Original languageEnglish (US)
Article number1048
JournalNature communications
Volume9
Issue number1
DOIs
StatePublished - Dec 1 2018

Fingerprint

Neuroendocrine Carcinoma
Large Cell Carcinoma
Neuroendocrine Tumors
lungs
Tumors
grade
tumors
cancer
Lung
cells
subgroups
Squamous Cell Carcinoma
Lung Neoplasms
Adenocarcinoma
bears
Up-Regulation
deactivation
markers
Epithelial Cells

All Science Journal Classification (ASJC) codes

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

Cite this

George, Julie ; Walter, Vonn ; Peifer, Martin ; Alexandrov, Ludmil B. ; Seidel, Danila ; Leenders, Frauke ; Maas, Lukas ; Müller, Christian ; Dahmen, Ilona ; Delhomme, Tiffany M. ; Ardin, Maude ; Leblay, Noemie ; Byrnes, Graham ; Sun, Ruping ; De Reynies, Aurélien ; McLeer-Florin, Anne ; Bosco, Graziella ; Malchers, Florian ; Menon, Roopika ; Altmüller, Janine ; Becker, Christian ; Nürnberg, Peter ; Achter, Viktor ; Lang, Ulrich ; Schneider, Peter M. ; Bogus, Magdalena ; Soloway, Matthew G. ; Wilkerson, Matthew D. ; Cun, Yupeng ; McKay, James D. ; Moro-Sibilot, Denis ; Brambilla, Christian G. ; Lantuejoul, Sylvie ; Lemaitre, Nicolas ; Soltermann, Alex ; Weder, Walter ; Tischler, Verena ; Brustugun, Odd Terje ; Lund-Iversen, Marius ; Helland, Åslaug ; Solberg, Steinar ; Ansén, Sascha ; Wright, Gavin ; Solomon, Benjamin ; Roz, Luca ; Pastorino, Ugo ; Petersen, Iver ; Clement, Joachim H. ; Sänger, Jörg ; Wolf, Jürgen ; Vingron, Martin ; Zander, Thomas ; Perner, Sven ; Travis, William D. ; Haas, Stefan A. ; Olivier, Magali ; Foll, Matthieu ; Büttner, Reinhard ; Hayes, David Neil ; Brambilla, Elisabeth ; Fernandez-Cuesta, Lynnette ; Thomas, Roman K. / Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors. In: Nature communications. 2018 ; Vol. 9, No. 1.
@article{3d3ddac3284044d78d655c54460fc93a,
title = "Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors",
abstract = "Pulmonary large-cell neuroendocrine carcinomas (LCNECs) have similarities with other lung cancers, but their precise relationship has remained unclear. Here we perform a comprehensive genomic (n = 60) and transcriptomic (n = 69) analysis of 75 LCNECs and identify two molecular subgroups: {"}type I LCNECs{"} with bi-allelic TP53 and STK11/KEAP1 alterations (37{\%}), and {"}type II LCNECs{"} enriched for bi-allelic inactivation of TP53 and RB1 (42{\%}). Despite sharing genomic alterations with adenocarcinomas and squamous cell carcinomas, no transcriptional relationship was found; instead LCNECs form distinct transcriptional subgroups with closest similarity to SCLC. While type I LCNECs and SCLCs exhibit a neuroendocrine profile with ASCL1 high/DLL3 high/NOTCH low, type II LCNECs bear TP53 and RB1 alterations and differ from most SCLC tumors with reduced neuroendocrine markers, a pattern of ASCL1 low/DLL3 low/NOTCH high, and an upregulation of immune-related pathways. In conclusion, LCNECs comprise two molecularly defined subgroups, and distinguishing them from SCLC may allow stratified targeted treatment of high-grade neuroendocrine lung tumors.",
author = "Julie George and Vonn Walter and Martin Peifer and Alexandrov, {Ludmil B.} and Danila Seidel and Frauke Leenders and Lukas Maas and Christian M{\"u}ller and Ilona Dahmen and Delhomme, {Tiffany M.} and Maude Ardin and Noemie Leblay and Graham Byrnes and Ruping Sun and {De Reynies}, Aur{\'e}lien and Anne McLeer-Florin and Graziella Bosco and Florian Malchers and Roopika Menon and Janine Altm{\"u}ller and Christian Becker and Peter N{\"u}rnberg and Viktor Achter and Ulrich Lang and Schneider, {Peter M.} and Magdalena Bogus and Soloway, {Matthew G.} and Wilkerson, {Matthew D.} and Yupeng Cun and McKay, {James D.} and Denis Moro-Sibilot and Brambilla, {Christian G.} and Sylvie Lantuejoul and Nicolas Lemaitre and Alex Soltermann and Walter Weder and Verena Tischler and Brustugun, {Odd Terje} and Marius Lund-Iversen and {\AA}slaug Helland and Steinar Solberg and Sascha Ans{\'e}n and Gavin Wright and Benjamin Solomon and Luca Roz and Ugo Pastorino and Iver Petersen and Clement, {Joachim H.} and J{\"o}rg S{\"a}nger and J{\"u}rgen Wolf and Martin Vingron and Thomas Zander and Sven Perner and Travis, {William D.} and Haas, {Stefan A.} and Magali Olivier and Matthieu Foll and Reinhard B{\"u}ttner and Hayes, {David Neil} and Elisabeth Brambilla and Lynnette Fernandez-Cuesta and Thomas, {Roman K.}",
year = "2018",
month = "12",
day = "1",
doi = "10.1038/s41467-018-03099-x",
language = "English (US)",
volume = "9",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",
number = "1",

}

George, J, Walter, V, Peifer, M, Alexandrov, LB, Seidel, D, Leenders, F, Maas, L, Müller, C, Dahmen, I, Delhomme, TM, Ardin, M, Leblay, N, Byrnes, G, Sun, R, De Reynies, A, McLeer-Florin, A, Bosco, G, Malchers, F, Menon, R, Altmüller, J, Becker, C, Nürnberg, P, Achter, V, Lang, U, Schneider, PM, Bogus, M, Soloway, MG, Wilkerson, MD, Cun, Y, McKay, JD, Moro-Sibilot, D, Brambilla, CG, Lantuejoul, S, Lemaitre, N, Soltermann, A, Weder, W, Tischler, V, Brustugun, OT, Lund-Iversen, M, Helland, Å, Solberg, S, Ansén, S, Wright, G, Solomon, B, Roz, L, Pastorino, U, Petersen, I, Clement, JH, Sänger, J, Wolf, J, Vingron, M, Zander, T, Perner, S, Travis, WD, Haas, SA, Olivier, M, Foll, M, Büttner, R, Hayes, DN, Brambilla, E, Fernandez-Cuesta, L & Thomas, RK 2018, 'Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors', Nature communications, vol. 9, no. 1, 1048. https://doi.org/10.1038/s41467-018-03099-x

Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors. / George, Julie; Walter, Vonn; Peifer, Martin; Alexandrov, Ludmil B.; Seidel, Danila; Leenders, Frauke; Maas, Lukas; Müller, Christian; Dahmen, Ilona; Delhomme, Tiffany M.; Ardin, Maude; Leblay, Noemie; Byrnes, Graham; Sun, Ruping; De Reynies, Aurélien; McLeer-Florin, Anne; Bosco, Graziella; Malchers, Florian; Menon, Roopika; Altmüller, Janine; Becker, Christian; Nürnberg, Peter; Achter, Viktor; Lang, Ulrich; Schneider, Peter M.; Bogus, Magdalena; Soloway, Matthew G.; Wilkerson, Matthew D.; Cun, Yupeng; McKay, James D.; Moro-Sibilot, Denis; Brambilla, Christian G.; Lantuejoul, Sylvie; Lemaitre, Nicolas; Soltermann, Alex; Weder, Walter; Tischler, Verena; Brustugun, Odd Terje; Lund-Iversen, Marius; Helland, Åslaug; Solberg, Steinar; Ansén, Sascha; Wright, Gavin; Solomon, Benjamin; Roz, Luca; Pastorino, Ugo; Petersen, Iver; Clement, Joachim H.; Sänger, Jörg; Wolf, Jürgen; Vingron, Martin; Zander, Thomas; Perner, Sven; Travis, William D.; Haas, Stefan A.; Olivier, Magali; Foll, Matthieu; Büttner, Reinhard; Hayes, David Neil; Brambilla, Elisabeth; Fernandez-Cuesta, Lynnette; Thomas, Roman K.

In: Nature communications, Vol. 9, No. 1, 1048, 01.12.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors

AU - George, Julie

AU - Walter, Vonn

AU - Peifer, Martin

AU - Alexandrov, Ludmil B.

AU - Seidel, Danila

AU - Leenders, Frauke

AU - Maas, Lukas

AU - Müller, Christian

AU - Dahmen, Ilona

AU - Delhomme, Tiffany M.

AU - Ardin, Maude

AU - Leblay, Noemie

AU - Byrnes, Graham

AU - Sun, Ruping

AU - De Reynies, Aurélien

AU - McLeer-Florin, Anne

AU - Bosco, Graziella

AU - Malchers, Florian

AU - Menon, Roopika

AU - Altmüller, Janine

AU - Becker, Christian

AU - Nürnberg, Peter

AU - Achter, Viktor

AU - Lang, Ulrich

AU - Schneider, Peter M.

AU - Bogus, Magdalena

AU - Soloway, Matthew G.

AU - Wilkerson, Matthew D.

AU - Cun, Yupeng

AU - McKay, James D.

AU - Moro-Sibilot, Denis

AU - Brambilla, Christian G.

AU - Lantuejoul, Sylvie

AU - Lemaitre, Nicolas

AU - Soltermann, Alex

AU - Weder, Walter

AU - Tischler, Verena

AU - Brustugun, Odd Terje

AU - Lund-Iversen, Marius

AU - Helland, Åslaug

AU - Solberg, Steinar

AU - Ansén, Sascha

AU - Wright, Gavin

AU - Solomon, Benjamin

AU - Roz, Luca

AU - Pastorino, Ugo

AU - Petersen, Iver

AU - Clement, Joachim H.

AU - Sänger, Jörg

AU - Wolf, Jürgen

AU - Vingron, Martin

AU - Zander, Thomas

AU - Perner, Sven

AU - Travis, William D.

AU - Haas, Stefan A.

AU - Olivier, Magali

AU - Foll, Matthieu

AU - Büttner, Reinhard

AU - Hayes, David Neil

AU - Brambilla, Elisabeth

AU - Fernandez-Cuesta, Lynnette

AU - Thomas, Roman K.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Pulmonary large-cell neuroendocrine carcinomas (LCNECs) have similarities with other lung cancers, but their precise relationship has remained unclear. Here we perform a comprehensive genomic (n = 60) and transcriptomic (n = 69) analysis of 75 LCNECs and identify two molecular subgroups: "type I LCNECs" with bi-allelic TP53 and STK11/KEAP1 alterations (37%), and "type II LCNECs" enriched for bi-allelic inactivation of TP53 and RB1 (42%). Despite sharing genomic alterations with adenocarcinomas and squamous cell carcinomas, no transcriptional relationship was found; instead LCNECs form distinct transcriptional subgroups with closest similarity to SCLC. While type I LCNECs and SCLCs exhibit a neuroendocrine profile with ASCL1 high/DLL3 high/NOTCH low, type II LCNECs bear TP53 and RB1 alterations and differ from most SCLC tumors with reduced neuroendocrine markers, a pattern of ASCL1 low/DLL3 low/NOTCH high, and an upregulation of immune-related pathways. In conclusion, LCNECs comprise two molecularly defined subgroups, and distinguishing them from SCLC may allow stratified targeted treatment of high-grade neuroendocrine lung tumors.

AB - Pulmonary large-cell neuroendocrine carcinomas (LCNECs) have similarities with other lung cancers, but their precise relationship has remained unclear. Here we perform a comprehensive genomic (n = 60) and transcriptomic (n = 69) analysis of 75 LCNECs and identify two molecular subgroups: "type I LCNECs" with bi-allelic TP53 and STK11/KEAP1 alterations (37%), and "type II LCNECs" enriched for bi-allelic inactivation of TP53 and RB1 (42%). Despite sharing genomic alterations with adenocarcinomas and squamous cell carcinomas, no transcriptional relationship was found; instead LCNECs form distinct transcriptional subgroups with closest similarity to SCLC. While type I LCNECs and SCLCs exhibit a neuroendocrine profile with ASCL1 high/DLL3 high/NOTCH low, type II LCNECs bear TP53 and RB1 alterations and differ from most SCLC tumors with reduced neuroendocrine markers, a pattern of ASCL1 low/DLL3 low/NOTCH high, and an upregulation of immune-related pathways. In conclusion, LCNECs comprise two molecularly defined subgroups, and distinguishing them from SCLC may allow stratified targeted treatment of high-grade neuroendocrine lung tumors.

UR - http://www.scopus.com/inward/record.url?scp=85044158627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044158627&partnerID=8YFLogxK

U2 - 10.1038/s41467-018-03099-x

DO - 10.1038/s41467-018-03099-x

M3 - Article

VL - 9

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

IS - 1

M1 - 1048

ER -